Presenter: Tina Kaczor, ND, FABNO

Original Date: March 5, 2016

In this presentation, you will be guided through a review of steroid receptor physiology as well as all adjunctive anti-estrogenic agents that are approved for use. Dr. Kaczor compares and contrasts the risks and benefits of SERM's vs. aromatase inhibitors. Dr. Kaczor also reviews evidence of natural agents for lessening side effects and optimizing outcomes, and evidence for natural agents that are most important for women who do not tolerate any anti-estrogenic agents.

1.0 Pharmacology CEUs approved by OBNM